BCR and chronic myelogenous leukemia, BCR-ABL1 positive: Because BCR/ABL protein kinase activates many different protein kinases involved in cell survival signaling pathways, thereby inhibiting cell differentiation and increasing the number of undifferentiated cells, the proliferation of CML cells is dysregulated and level of apoptotic cells is decreased, resulting in immortalization [1,2].